[Serological markers of selected viral infections transmitted by parenteral route in drug addicts] NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Serological markers of selected viral infections transmitted by parenteral route in drug addicts]

Przegl Epidemiol. 1991;45(4):347-9. Unique Identifier : AIDSLINE MED/93029565
Halota W; Opoka J; Trzcinski J; Dorau M; Topczewska E; Gizinski W; Bulik F; Klinika Chorob Zakaznych Akademii Medycznej, Bydgoszczy.

Abstract: Investigations included a group 80 asymptomatic drug addicts. They were examined immunoenzyme method aiming at detection infection by HIV, HBV, HCV and HDV. Cases of seropositive HIV results were confirmed by means WB. In 68 examined patients serological evidence of virus HBV was discovered. In 60 of them one also found out coexisting HIV serological markers, in 51 of HCV markers. HDV antibodies were disclosed in 7 cases. Infection with hepatotropic viruses were more frequent in group of HIV(+) drug addicts.
Keywords: Acquired Immunodeficiency Syndrome/*DIAGNOSIS/ETIOLOGY/IMMUNOLOGY/ TRANSMISSION Adolescence Adult Biological Markers Delta Agent/IMMUNOLOGY Delta Infection/*DIAGNOSIS/ETIOLOGY/IMMUNOLOGY/TRANSMISSION English Abstract Female Hepatitis Antibodies/ANALYSIS Hepatitis B/*DIAGNOSIS/ETIOLOGY/IMMUNOLOGY/TRANSMISSION Hepatitis B Virus/IMMUNOLOGY Hepatitis C/*DIAGNOSIS/ETIOLOGY/IMMUNOLOGY/TRANSMISSION Hepatitis C Viruses/IMMUNOLOGY Human HIV Antibodies/ANALYSIS HIV-1/IMMUNOLOGY Male Poland Substance Abuse, Intravenous/*COMPLICATIONS JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDdiagnosis/etiology/immunology/transmissionadolescenceadultbiologicalmarkersdeltaagent/immunologydeltainfection/KWDdiagnosis/etiology/immunology/transmissionenglishabstractfemalehepatitisantibodies/analysishepatitisb/KWDdiagnosis/etiology/immunology/transmissionhepatitisbvirus/immunologyhepatitisc/KWDdiagnosis/etiology/immunology/transmissionhepatitiscviruses/immunologyhumanhivantibodies/analysishiv-1/immunologymalepolandsubstanceabuse,intravenous/KWDcomplicationsjournalarticle
930130
M9311132

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .